Trellus Management Company, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Trellus Management Company, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2019$236,000
+116.5%
26,845
+127.1%
0.24%
+60.1%
Q2 2019$109,000
-36.6%
11,821
-55.9%
0.15%
-54.9%
Q1 2019$172,000
-23.2%
26,821
+118.9%
0.33%
+22.8%
Q1 2015$224,000
-29.1%
12,252
-28.6%
0.27%
-42.5%
Q4 2014$316,000
-23.1%
17,152
-59.9%
0.46%
+32.6%
Q3 2014$411,000
-3.3%
42,800
-7.6%
0.35%
-2.2%
Q2 2014$425,000
-15.0%
46,3000.0%0.36%
-19.7%
Q1 2014$500,00046,3000.45%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2019
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders